Literature DB >> 11773882

Transplantation of mouse pancreatic islets into primates--in vivo and in vitro evaluation.

L Badet1, T T Titus, P McShane, L W Chang, Z Song, D J Ferguson, D W Gray.   

Abstract

BACKGROUND: Islets transplanted from other species to man has the potential to cure diabetes but whether islets are subject to hyperacute rejection after xenotransplantation is contentious. We transplanted mouse pancreatic islets of mouse beneath the primate renal capsule and assessed natural xenoantibody binding, complement activation and cell lysis in vitro.
METHODS: Freshly isolated mouse islets were transplanted in a blood clot under the renal capsule of cynolmogus monkeys. The graft was removed after 24 hr for histological and ultrastructural analysis. Freshly isolated mouse pancreatic islets were analyzed in vitro by immunohistochemistry for Gal(alpha1,3)Gal and Von Willebrand factor expression and for IgG, IgM, C3, C4, and C5b-9 binding after incubation in 100% human serum. Complement mediated cell lysis was evaluated by 51Cr release assays after incubation of islets for 4 hr in human serum, plasma, and lymph with and without added neutrophils.
RESULTS: Mouse islets transplanted under the renal capsule of cynomolgus monkeys were destroyed within 24 hr by a process involving necrosis with neutrophil and mononuclear cell infiltration. Gal(alpha1,3)Gal was strongly positive on only 10% of islet cells. After islet incubation in 100% human serum before frozen section, human IgG and IgM, C3, C4, and C5b-9 was deposited on islets with increased intensity in the periphery. Measurement of 51Cr release from labeled fresh islets after four hours incubation in 100% human serum showed 17% lysis and was not changed by addition of neutrophils.
CONCLUSION: These results indicate that mouse islets in a primate recipient undergo rapid destruction by a process that has features similar to hyperacute rejection in vascularized organs and we propose the same term be used.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11773882     DOI: 10.1097/00007890-200112270-00002

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

1.  Ultrathin polymeric coatings based on hydrogen-bonded polyphenol for protection of pancreatic islet cells.

Authors:  Veronika Kozlovskaya; Oleksandra Zavgorodnya; Yi Chen; Kristin Ellis; Hubert M Tse; Wanxing Cui; J Anthony Thompson; Eugenia Kharlampieva
Journal:  Adv Funct Mater       Date:  2012-04-30       Impact factor: 18.808

Review 2.  Pancreatic islet xenotransplantation: barriers and prospects.

Authors:  Gina R Rayat; Ronald G Gill
Journal:  Curr Diab Rep       Date:  2003-08       Impact factor: 4.810

3.  Biomolecular surface engineering of pancreatic islets with thrombomodulin.

Authors:  John T Wilson; Carolyn A Haller; Zheng Qu; Wanxing Cui; Murali K Urlam; Elliot L Chaikof
Journal:  Acta Biomater       Date:  2010-01-25       Impact factor: 8.947

4.  Vascular endothelial growth factor gene delivery for revascularization in transplanted human islets.

Authors:  Ajit S Narang; Kun Cheng; James Henry; Chunxiang Zhang; Omaima Sabek; Daniel Fraga; Malak Kotb; A Osama Gaber; Ram I Mahato
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.